Close
Close
Treatment Database
4-hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-one
Trade Name not avaiable
Orphan Indication Friedreich’s ataxia
EU Market Approval
EU Designation Date 01-04-2019
Sponsor Takeda Pharma A/S
More about Friedreich Ataxia
Free Newsletter
Related Videos
by Abidemi Uruejoma
612 views
by Abidemi Uruejoma
11,484 views
by Abidemi Uruejoma
29,221 views